Kelsey Erin Shaw

Title: Kelsey Erin Shaw: Innovator in Cancer Treatment

Introduction

Kelsey Erin Shaw is a prominent inventor based in Atlanta, GA (US). She has made significant contributions to the field of cancer treatment through her innovative research and development of ENPP1 inhibitors. With a total of 2 patents to her name, Shaw is dedicated to advancing medical science and improving patient outcomes.

Latest Patents

Shaw's latest patents focus on ENPP1 inhibitors and their use for the treatment of cancer. These patents provide compounds, compositions, and methods for inhibiting ENPP1, which plays a crucial role in cancer progression. The methods include contacting a sample with an ENPP1 inhibitor to inhibit cGAMP hydrolysis activity of ENPP1. In some instances, the ENPP1 inhibitor is cell impermeable. The patents also detail methods for treating cancer by administering a therapeutically effective amount of an ENPP1 inhibitor to a subject. This treatment is particularly relevant for solid tumor cancers. Additionally, the patents describe methods of administering radiation therapy either before or after the ENPP1 inhibitor, aiming to reduce radiation damage to the subject. The methods can be performed in combination with chemotherapeutic agents or checkpoint inhibitors.

Career Highlights

Kelsey Erin Shaw is affiliated with Leland Stanford Junior University, where she continues her research and development efforts. Her work has garnered attention for its potential to revolutionize cancer treatment and improve therapeutic strategies.

Collaborations

Shaw collaborates with notable colleagues, including Lingyin Li and Mark Smith, to further her research initiatives and enhance the impact of her inventions.

Conclusion

Kelsey Erin Shaw is a trailblazer in the field of cancer treatment, with her innovative patents paving the way for new therapeutic approaches. Her dedication to research and collaboration exemplifies the spirit of innovation in the medical field.